Français Néerlandais Japonais Chinois Allemand Espagnol Portugais

New biopharma start-up at Lille's Institut Pasteur

10 Aug 2016 | Health Nutrition, A region on the move

A revolutionary start-up has just seen the light of day at the Institut Pasteur campus in Lille. Immune InsighT is a biotech business specialized in analyses to confirm new drug candidates are safe. The company harnesses rare expertise to offer a unique services to clients around the world.

Lille's Institut Pasteur is an international pace-setter and a key player in medical research. Over the past fifteen years, a dozen start-ups have been set up on its campus or through its research teams—including Immune InsighT in 2016.

Immune InsighT offers an all-new, high-end method for confirming the safety of new drug candidates designed to treat cancer, transplants, auto-immune system and inflammatory illnesses, and applications in agrifood and the cosmetic industry prior to the launch of clinical tests. This fast-moving young company offers unique services worldwide.

Completing the full range of tests offered by Immune InsighT early on enables client companies to identify the undesirable effects of drug candidates or other molecules on the immune system both reliably and quickly—and to anticipate the potential failure of a long and costly clinical trial well in advance. 

 

Source: Lille's Institut Pasteur

Back to news

News

Hauts-de-France in pole position for investment by Renault

Automobile manufacturer Renault has chosen France as an industrial base for its electric vehicles. More than €1 billion will be invested by 2022, on its top four production sites: Douai, Maubeuge, Flins and...

Hauts-de-France, specialists in sustainable transport

Created in 2009, Transalley (Sustainable and Innovative Mobility Technology Park) has not stopped developing. Review of a cluster with international ambition and its future facilities for supporting...

All news